Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-01-17 @ 6:12 AM
Study NCT ID:
NCT03052751
Status:
COMPLETED
Last Update Posted:
2021-08-03
First Post:
2017-02-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
Sponsor:
UCB Biopharma S.P.R.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-06
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-10
First Submit QC Date:
None
Study First Post Date:
2017-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-28
Results First Submit QC Date:
None
Results First Post Date:
2021-08-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-08-03
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-07-12
Last Update Post Date:
2021-08-03
Last Update Post Date Type:
ACTUAL